Analyst consensus rating
Myriad Genetics Analyst Rating: Hold
Direct answer
Myriad Genetics's consensus rating is Hold.
8 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $3.34.
Forecast evidence checked September 8, 2026.
Get free Myriad Genetics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $3.18
- Average price target
- $3.34
- High price target
- $5.00
- Low price target
- $2.00
- Low target gap
- -37.1%
- Target upside
- +5%
- High target gap
- +57.2%
- Target range width
- 94.3%
- Consensus rating
- Hold
- Analysts
- 8
- Evidence date
- September 8, 2026
- Valid through
- September 15, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Myriad Genetics?
Myriad Genetics has a verified Hold consensus. The same dataset has an average price target of $3.34.
How far are Myriad Genetics's low and high targets from the recorded price?
The low target implies -37.1%, while the high target implies +57.2%.
How many analysts are included in Myriad Genetics's consensus?
The verified consensus includes 8 analysts.
How is Myriad Genetics's target upside or downside calculated?
The average target of $3.34 is divided by the recorded price of $3.18, then one is subtracted to produce +5%. This does not guarantee a future return.
When was Myriad Genetics's analyst forecast verified?
The data was verified on 2026-09-08. The dataset is valid through 2026-09-15.